Lingrui Pharmaceuticals: Director Chen Yan intends to reduce holdings by no more than 200,000 shares.

Lingrui Pharmaceuticals announced on September 15th that director Chen Yan plans to sell no more than 200,000 shares of the company through centralized bidding trading within 3 months after 15 trading days from the disclosure date of the announcement, due to personal financial needs. This represents no more than 0.0353% of the total share capital of the company. The selling price will be determined based on the market price at the time of the sale.